COVID-19 Pandemic Impact on Global Yellow Fever Vaccine Market
The COVID-19 pandemic has resulted in a paradigm shift in the approach towards health and wellbeing amongst individuals. Government bodies are increasingly utilizing lockdown and social distancing measures to prevent the spread of the virus. Despite the rolling out of COVID-19 vaccines in several countries, cases have been rising in countries like the U.S., India, the UK and Germany, amongst others. In Africa and South America, the threat of yellow fever still looms, and the COVID-19 pandemic has increased the focus on vaccination drives. The situation where yellow fever victims contract COVID-19 can lead to complications in the future, and hence, yellow fever vaccines are being made increasingly available for public use. As international travel is going back to the pre-pandemic situation, yellow fever vaccines are also being mandated for travel to countries that are categorized under the high risk category for yellow fever. The primary issue with yellow fever is that the onset of symptoms is slow, and it is highly difficult to diagnose the cases in the absence of sophisticated methods. Majority of the cases are in countries that have an underdeveloped healthcare system, which in turn increases the chances of non detection of cases. The pandemic is therefore expected to have a huge impact on the global yellow fever vaccine market, as the production of these vaccines are expected to pick up in the coming years.
Browse the full Report with TOC at:https://www.absolutemarketsinsights.com/reports/Global-Yellow-Fever-Vaccine-Market-2021---2029-1034
Yellow Fever Vaccines are Being Increasingly Distributed through Government Vaccination Campaigns
Based on Absolute Markets Insights' findings, government bodies are spearheading the vaccination campaigns, especially in yellow fever affected areas in Africa and South America. Based on studies by the World Health Organization, it has been found that a dose of yellow fever vaccine can protect an individual for a period of around 35 years. These vaccines are cost-effective, produce high results, and are relatively safe for use in individuals. Government campaigns are effective in vaccinating individuals, especially in rural and semi-urban areas. The Ghanaian Ministry of Health, in partnership with Ghana Health Service, and other organizations such as the WHO and the UNICEF, conducted a mass vaccination campaigns in Ghana from 12th to 18th November, 2020. In other instance, the Brazilian government had launched a vaccination campaign in 2018 in the municipalities in Rio De Janeiro and Sao Paulo, and around 23.8 individuals were expected to be vaccinated during the immunization drive. The campaign was supported by the Pan American Health Organization (PAHO) and the WHO. The standard dose of the vaccine was primarily provided to children between the ages of nine months and two years, and people who were suffering from medical conditions. In 2017, the Brazilian government had sought the support of the PAHO for the control of yellow fever causing mosquitoes in Bahia, Rio de Janeiro, Minas Gerais, and Espírito Santo. Based on statistics from the Brazilian Ministry of Health, around 130 confirmed cases of yellow fever was reported in the country from July 1, 2017 to January 23, 2018, and 53 individuals perished due to the disease. Government vaccination campaigns are expected to gain momentum in the coming years, thus leading to the growth of the revenue in the global yellow fever vaccine market.
North America Region is Witnessing a Growth in Adoption of Yellow Fever Vaccine
The U.S. government has recommended the immunization of individuals who are travelling to high risk countries. Sanofi Pasteur's YF-VAX is provided in the U.S. Individuals above the age of nine months that are living in high risk areas, or planning to travel to these areas can obtain the vaccines from healthcare providers. The providers need to obtain Yellow Fever Vaccination Stamp, which is provided by the state health department. For a travel to Ghana, for instance, yellow fever vaccines are required for travellers from all countries, if they are above nine months old. The rise in awareness about yellow fever outbreak in certain countries in Africa and South America, coupled with the increase in travel to these countries for tourism and business purposes, is leading to the growth of the yellow fever vaccine market in North America.
The global yellow fever vaccine market was is expected to growth at 8.92% CAGR during the forecast years (2021-2029).
Request for a Sample Copy of this Report:https://www.absolutemarketsinsights.com/request_sample.php?id=1034
Why One Should Purchase Reports from Absolute Market Insights:
The research report on Global Yellow Fever Vaccine Market will include in-depth qualitative and quantitative information on the following pointers:
- We offer our reports in different languages which include German, Japanese, French, Spanish and Korean amongst others.
- We offer the feasibility of customizing the reports specific to regions which will cover exclusive insights on regions and its countries (namely North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
- Global Market Size and Forecast Values (2015 – 2029), in terms of revenue (US$ Million) by segments/sub-segments wherein 2015 to 2019 has been considered as historic years, 2020 as the base year, while 2021 to 2029 has been considered as the forecast period.
- Split of the market revenue (US$ Million) into all the relevant segments & sub-segments across all major regions/countries.
- Macro-Economic and Micro-Economic Indicators: Global Yellow Fever Vaccine Market
- Market Determinants and Influencing Factors
- Macro-Economic and Micro-Economic Indicators
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends in Global Yellow Fever Vaccine Market
- Impact of the Pandemic on Global Yellow Fever Vaccine Market
- Competitor Landscape
- Product Benchmarking
- Market Share Analysis and Positioning, 2020
- Global Presence and Growth Strategies
- The final report will include competitive product benchmarking which will include comparison of different products offered by different market key players on the basis of their features and capabilities that will help you to understand their market offerings. Furthermore, for each company, we will provide information on company details, company overview, product offerings, key developments, financial analysis, swot analysis, business strategies.
Competitors:
Few of the key players operating in the global yellow fever vaccine market are:
- Bio-Manguinhos
- Central Research Institute Kasauli
- FSUE Chumakov
- iBio
- Institut Pasteur de Dakar
- Sanofi
- Other Market Participants
Enquiry Before Buying this Report:https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1034
Global Yellow Fever Vaccine Market
By Clinical Trials
- Pre Clinical Trial
- Phase 1 Clinical Trial
- Others
By Application
- Kids
- Adults
By End-User
- Healthcare Facilities
- Government Vaccination Campaigns
- Research Facilities
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Click here for Instant Purchase of this Report: https://www.absolutemarketsinsights.com/checkout?id=1034
More Trending Reports:
- Global Gaming Accessories Market
- Global Insulated-Gate Bipolar Transistor (IGBT) Market
- Global KVM Market
Contact Us:
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +917400242424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/